Paraneoplastic neurological syndromes

Por Leypoldt, F, Wandinger, K-P
Publicado em 2014

Successful immunosuppressive treatment and long‐term follow‐up of anti‐Ri‐associated paraneoplastic myelitis

Por Leypoldt, F, Eichhorn, P, Saager, C, Münchau, A, Lewerenz, J
Publicado em 2006

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature

Por Jarius, S., Ruprecht, K., Stellmann, J. P., Huss, A., Ayzenberg, I., Willing, A., Trebst, C., Pawlitzki, M., Abdelhak, A., Grüter, T., Leypoldt, F., Haas, J., Kleiter, I., Tumani, H., Fechner, K., Reindl, M., Paul, F., Wildemann, B.
Publicado no J Neuroinflammation (2018)

S1 guidelines “lumbar puncture and cerebrospinal fluid analysis” (abridged and translated version)

Por Tumani, H., Petereit, H. F., Gerritzen, A., Gross, C. C., Huss, A., Isenmann, S., Jesse, S., Khalil, M., Lewczuk, P., Lewerenz, J., Leypoldt, F., Melzer, N., Meuth, S. G., Otto, M., Ruprecht, K., Sindern, E., Spreer, A., Stangel, M., Strik, H., Uhr, M., Vogelgsang, J., Wandinger, K.-P., Weber, T., Wick, M., Wildemann, B., Wiltfang, J., Woitalla, D., Zerr, I., Zimmermann, T.
Publicado no Neurol Res Pract (2020)